FKBP5 and melanoma: An increased production of the TRAIL-ligand TNFSF10 along with a decrease of the decoy receptor TNFRSF10c (Pan et al., 1997) suggest that additional factors to DR5 could contribute to the improved apoptosis susceptibility of FKBP51-targeted melanoma cells.